Nadecnemab

Tax included
Nadecnemab is an IgG4κ antibody targeting to GFRA3, glial cell derived neurotrophic factor family receptor alpha 3. Nadecnemab can be used for research of osteoarthritis of the knee/pain.
HY-P99748

Data sheet

Size
Multiple sizes
Reactivity
TGF-β Receptor